Courage Capital Management LLC Dbv Technologies S.A. Transaction History

Courage Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$5.75 - $21.85 $118,133 - $448,908	-20,545 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$20.86 - $26.6 $197,231 - $251,503	-9,455 Reduced 31.52%	20,545 $474,000
Q4 2017 Feb 14, 2018	SELL	$20.9 - $49.36 $313,500 - $740,400	-15,000 Reduced 33.33%	30,000 $738,000
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $594,300 - $692,550	15,000 Added 50.0%	45,000 $1.91 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,000	30,000 $1.07 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $792M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Courage Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Courage Capital Management LLC with notifications on news.